Assessing the burden of disease-modifying therapies (DMTs) to enable the planning of specialist healthcare services for relapsing MS.

A review on what causes the early termination of clinical studies and what sponsors can do to improve their pipeline productivity and prevent ceasing development.

In an area like childhood cancer, broad benefits will flow from a global Warp Speed mindset that combines a spirit of urgency, coordination and imagination. 

Recommendations to engage sickle cell disease patients more fully in clinical trials based on patient and caregiver insight collected by Syneos Health.

Webinar hosted by Syneos Health featuring an engaging panel discussion on how medical affairs teams are uniquely positioned to infuse the voice of the patient into drug development...

Valuable insights into the evolving field of ophthalmology and the efforts to address the growing burden of age-related vision impairment.